Elevated CK Levels Found in Pneumonia - Medscape
Mar 12, 2004 · Some patients presenting with pneumonia have elevated CK levels. What is the pathophysiology behind this, and does this finding have any clinical relevance?
Absolute CK-MB vs. CK-MB Relative Index for Cardiac Risk
These researchers compared the predictive values of the CK-MB relative index and the initial absolute CK-MB for diagnosing AMI, ACS, and serious cardiac events (SCEs) in consecutive …
Biomarkers as Predictors of Outcome After Cardiac Arrest
The measurement of CK, especially the isoenzyme CK-MB, is considered as an alternative to Tn measurement to detect heart injury, but only if this latter is not available.
Unexpected Cause of Myopathy in Sjogren's: Crack the Case
Oct 11, 2019 · In addition, exercise in unaccustomed individuals, especially when performing eccentric contractions, may cause an elevation in CK level that improves with rest within days …
AML: Clinical Data Confirms Lower Survival in Black Patients
Cytogenetic risk doesn't seem to explain the disparity in mortality of Black vs White patients, a study across 10 clinical trials suggests.
ISAR-COOL: The Intracoronary Stenting with Antithrombotic …
Dec 2, 2002 · Important exclusion criteria were ST elevation, CK-MB > 18 U/L, hemodynamic instability, contraindications to 1 of the study medications, or missing consent.
New Blood Test for Prostate Cancer Claims 94% Accuracy
Feb 10, 2023 · They said that the test, developed by Oxford BioDynamics in collaboration with UEA, ICL, and Imperial College NHS Trust, could detect prostate cancer with 94% accuracy, …
NICE Updates Quality Standards for UTI in Adults - Medscape
Feb 16, 2023 · NICE issues new and updated quality standards for improvements in UTI diagnosis for adults.
Fasting Before Bloodwork Is Outdated for Most Patients - Medscape
Jul 17, 2025 · Dr Christopher Labos discusses why fasting blood tests are no longer needed.
Tirzepatide Linked to Superior Kidney Outcomes in T2D - Medscape
Jan 15, 2025 · In people with type 2 diabetes and high cardiovascular risk, tirzepatide was associated with slower kidney function decline compared with placebo, semaglutide, and insulin.